Evidence map›Paper›PMID 19757017›Full record

Trial reportAIDS and behavior2010

Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.

Ana Ventuneac, Alex Carballo-Diéguez, Ian McGowan, Robert Dennis, Amy Adler, Elena Khanukhova, Charles Price, Terry Saunders, Chomchay Siboliban, Peter Anton

Abstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. On-demand microbicide products: design matters.Drug delivery and translational research · 2017
    Review
  6. Lubricant Provides Poor Rectal Mucosal HIV Coverage.AIDS research and human retroviruses · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Rectal microbicide development.Current topics in microbiology and immunology · 2014
    Review
  16. Article
  17. Article
  18. Rectal microbicide development.Current opinion in HIV and AIDS · 2012
    Review
  19. Microbicides for HIV prevention.The Indian journal of medical research · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana VentuneacHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, Unit 15, New York, NY 10032, USA. ventune@pi.cpmc.columbia.edu
Alex Carballo-Diéguez
Ian McGowan
Robert Dennis
Amy Adler
Elena Khanukhova
Charles Price
Terry Saunders
Chomchay Siboliban
Peter Anton

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
Regulatory compliance and human subjects safetyU19AI060614 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 2004 to 2009
$19.1M
NIAID NIH HHS AI060614NIAID NIH HHS U19 AI060614NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

We studied the overall acceptability of UC781 gel formulation when applied rectally. Ten women and twenty-six men, all HIV-uninfected, were enrolled in a Phase 1, randomized, blinded, placebo-controlled safety and acceptability study of the vaginal microbicide gel UC781 applied rectally. Participants were randomized to three groups: 0.1% UC781 gel, 0.25% UC781 gel, or a placebo gel. Acceptability was assessed using structured questionnaires and qualitative in-depth interviews. After using UC781 gel rectally for seven consecutive days, participants' reports suggest that a UC781 gel formulation is highly acceptable and comparable to a placebo gel. The gels received favorable ratings overall and on attributes such as color, smell and consistency. All of the participants reported high intentions to use a gel like the one they used in this study. Acceptability research is essential in early phases of microbicide development to identify potential problems, understand user preferences, and introduce changes if needed.

Indexed as

Administration, RectalPatient Acceptance of Health CareAdolescentAnilidesFemaleFuransHIV InfectionsHumansInterviews as TopicMaleSexual BehaviorSingle-Blind MethodSurveys and QuestionnairesThioamidesVaginal Creams, Foams, and JelliesYoung AdultAnilidesFuransThioamidesUC-781Vaginal Creams, Foams, and Jellies

Identifiers

PMID19757017
PMCPMC2865630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.